Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression (Q41470466)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 August 2015

Language	Label	Description	Also known as
English	Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression	scientific article published on 19 August 2015

Statements

scholarly article

1 reference

Europe PubMed Central

1 October 2017

Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression (English)

1 reference

Europe PubMed Central

1 October 2017

immunosuppression

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

1 October 2017

author name string

M F Nijhoff

1

1 reference

Europe PubMed Central

1 October 2017

M A Engelse

2

1 reference

Europe PubMed Central

1 October 2017

J Dubbeld

3

1 reference

Europe PubMed Central

1 October 2017

A E Braat

4

1 reference

Europe PubMed Central

1 October 2017

J Ringers

5

1 reference

Europe PubMed Central

1 October 2017

D L Roelen

6

1 reference

Europe PubMed Central

1 October 2017

A R van Erkel

7

1 reference

Europe PubMed Central

1 October 2017

H S Spijker

8

1 reference

Europe PubMed Central

1 October 2017

H Bouwsma

9

1 reference

Europe PubMed Central

1 October 2017

P J M van der Boog

10

1 reference

Europe PubMed Central

1 October 2017

J W de Fijter

11

1 reference

Europe PubMed Central

1 October 2017

E J P de Koning

13

1 reference

Europe PubMed Central

1 October 2017

language of work or name

0 references

publication date

19 August 2015

1 reference

Europe PubMed Central

1 October 2017

American Journal of Transplantation

1 reference

Europe PubMed Central

1 October 2017

16

1 reference

Europe PubMed Central

1 October 2017

246-253

1 reference

Europe PubMed Central

1 October 2017

1

1 reference

Europe PubMed Central

1 October 2017

Islet transplantation in type 1 diabetes: hype, hope and reality - a clinician's perspective

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Islet transplantation as a treatment for diabetes - a work in progress

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

International trial of the Edmonton protocol for islet transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Improvement in outcomes of clinical islet transplantation: 1999-2010.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Five-year follow-up after clinical islet transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

State of the art of clinical islet transplantation and novel protocols of immunosuppression

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Chemical immunosuppression in islet transplantation--friend or foe?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Assessing the effect of immunosuppression on engraftment of pancreatic islets

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Minimization and withdrawal of steroids in pancreas and islet transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Beta-score: an assessment of beta-cell function after islet transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Human islet separation utilizing a closed automated purification system.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Steroid avoidance or withdrawal in kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Recovery from diabetes in mice by beta cell regeneration

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-scor

1 reference

https://api.crossref.org/works/10.1111%2FAJT.13425

21 January 2018

Identifiers

10.1111/AJT.13425

1 reference

Europe PubMed Central

1 October 2017

1 reference

Europe PubMed Central

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41470466&oldid=1922038475"